Glucose Regulation Beyond HbA in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort.

Objective: To investigate glucose variations associated with glycated hemoglobin (HbA) in insulin-treated patients with type 2 diabetes.

Research Design And Methods: Patients included in Diabetes and Lifestyle Cohort Twente (DIALECT)-2 ( = 79) were grouped into three HbA categories: low, intermediate, and high (≤53, 54-62, and ≥63 mmol/mol or ≤7, 7.1-7.